Updates in Sarcoma Management

Thursday, June 17, 2021, 5:00 PM - 6:00 PM

This virtual event provided by the Rutgers Cancer Institute of New Jersey will discuss the latest treatment and management of patients with sarcomas.

1. Develop multidisciplinary diagnosis and initial treatment strategies of localized disease in order to improve quality of care and optimize outcomes
2. Explain the unique biology of sarcomas and the importance of accurate diagnosis including incorporation of genomic testing
3. Discuss practice changing data for advanced disease along with critical review of combination as well as second-line or later therapies
4. Assess available clinical trials and discuss targeted therapies currently in development for sarcomas

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity is awarded 1.0 contact hour. (60 minute CH)

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Contact Hours (1.00 hours), Non-Physician Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

All relevant financial relationships for all individuals in control of content have been mitigated.

No faculty are available for this activity at this time.